DFTX Definium Therapeutics, Inc. CIK 0001813814 · last filing 2d ago · 5 insider transactions
$2.62M
5 sell transactions
Total flow
$2.62M
5 priced transactions
cross-source convergence Divergent 3/5 sources
Insider Funds Activist Sell Events 14 / 100 Recent disclosures · timeline Form 4 2d ago
Chief Financial Officer · sold $135.7K
Form 4 2d ago
Chief Legal Officer · sold $585.8K
Form 4 2d ago
Chief Medical Officer · sold $451.9K
Form 4 2d ago
Chief Executive Officer · Director · sold $1.32M
Form 4 2d ago
Price · DFTX Live chart by TradingView Most recent insider trade: Sold 3,013 sh @ $45.03 on Jun 25, 2026 view filing → Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
DFTX insider flow· last 30 days net -$2.62M
max $2.62M/day May 27 — buy $0 · sell $0 · net +$0 May 28 — buy $0 · sell $0 · net +$0 May 29 — buy $0 · sell $0 · net +$0 May 30 — buy $0 · sell $0 · net +$0 May 31 — buy $0 · sell $0 · net +$0 Jun 1 — buy $0 · sell $0 · net +$0 Jun 2 — buy $0 · sell $0 · net +$0 Jun 3 — buy $0 · sell $0 · net +$0 Jun 4 — buy $0 · sell $0 · net +$0 Jun 5 — buy $0 · sell $0 · net +$0 Jun 6 — buy $0 · sell $0 · net +$0 Jun 7 — buy $0 · sell $0 · net +$0 Jun 8 — buy $0 · sell $0 · net +$0 Jun 9 — buy $0 · sell $0 · net +$0 Jun 10 — buy $0 · sell $0 · net +$0 Jun 11 — buy $0 · sell $0 · net +$0 Jun 12 — buy $0 · sell $0 · net +$0 Jun 13 — buy $0 · sell $0 · net +$0 Jun 14 — buy $0 · sell $0 · net +$0 Jun 15 — buy $0 · sell $0 · net +$0 Jun 16 — buy $0 · sell $0 · net +$0 Jun 17 — buy $0 · sell $0 · net +$0 Jun 18 — buy $0 · sell $0 · net +$0 Jun 19 — buy $0 · sell $0 · net +$0 Jun 20 — buy $0 · sell $0 · net +$0 Jun 21 — buy $0 · sell $0 · net +$0 Jun 22 — buy $0 · sell $0 · net +$0 Jun 23 — buy $0 · sell $0 · net +$0 Jun 24 — buy $0 · sell $0 · net +$0
Institutional holders · 13F Q1 2026 vs Q4 2025 · live SEC data 1 fund holds $160.28M reported value Net accumulating(1 adding · 0 reducing)
Fund Shares Value % of portfolio QoQ BlackRock Inc 8,480,230 $160.28M 0.0% New
Proposed sales · Form 144 selling intent · live SEC data 5 notices $2.45M proposed to sell 0/5 under a 10b5-1 plan
Filed Filer Shares Est. value Approx. sale Source of shares Plan 3d ago MARK SULLIVAN
Officer
13,008 $548.0K Jun 25, 2026 Restricted Stock Vesting Under a Registered Plan Discretionary 3d ago BRANDI ROBERTS
Officer
3,013 $126.9K Jun 25, 2026 Restricted Stock Vesting Under a Registered Plan Discretionary
Recent insider transactions Filed Insider Transaction Shares Price Value Signal Flags 2d ago
Jun 25, 2026
Roberts Brandi Chief Financial Officer
3,013 $45.03 $135.7K Neutral +4 2d ago
Jun 25, 2026
Sullivan Mark Chief Legal Officer
13,008 $45.03 $585.8K Neutral +1 2d ago
Jun 25, 2026
Karlin Daniel Chief Medical Officer
10,035 $45.03 $451.9K Neutral +1 2d ago
Jun 25, 2026
Barrow Robert Chief Executive Officer · Director
29,208 $45.03 $1.32M Neutral +4 2d ago
Jun 25, 2026
Wiley Matthew T. Chief Commercial Officer
2,867 $45.03 $129.1K Neutral +5
I Insider · Net insider selling F Institutional · 1 fund, +1 new A Activist · — S Sell pressure · $2.45M planned E Events · — Institutions are accumulating (1 fund, 1 new). Form 144 shows $2.45M of planned insider selling and insiders are net sellers.
Institutions accumulating+12 New institutional position (1)+8 Planned insider selling (Form 144, $2.45M)-6
Convergence is a transparent heuristic sum of attributable disclosure factors — not a price target or recommendation. 8-K events are shown as context; Form 144 planned sales count against bullish conviction. Not financial advice.
Chief Commercial Officer · sold $129.1K
Form 144 3d ago
Proposed sale of 13,008 sh ($548.0K) · discretionary
Form 144 3d ago
Proposed sale of 3,013 sh ($126.9K) · discretionary
Form 144 3d ago
Proposed sale of 2,867 sh ($120.8K) · discretionary
Jun 25 — buy $0 · sell $2.62M · net -$2.62M May 27 Jun 25 3d ago MATTHEW THOMAS WILEY
Officer
2,867 $120.8K Jun 25, 2026 Restricted Stock Vesting Under a Registered Plan Discretionary
3d ago ROBERT B BARROW
Officer, Director
29,208 $1.23M Jun 25, 2026 Restricted Stock Vesting Under a Registered Plan Discretionary
3d ago DANIEL ROLLINGS KARLIN
Officer
10,035 $422.8K Jun 25, 2026 Restricted Stock Vesting Under a Registered Plan Discretionary
DFTXDefinium Therapeutics, Inc.